Sodium-glucose Co-transporter 2 Inhibitors Effects in Failing Heart Patients

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 100 participants.

Also called NCT03977116

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose prevention
Phase
Phase 4
Enrolled
  • 100 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT03977116
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Italy (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT03977116. Randomized; single masking; primary purpose prevention. Start 2017-01-01 (actual); primary completion 2019-01-01 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Sodium-glucose Co-transporter 2 Inhibitors Effects in Failing Heart Patients
Condition
Diabetes Mellitus
Condition
Heart Failure
Condition
Ventricular Arrythmia
Intervention (Drug)
SLGT2
Intervention (Drug)
Placebo
Lead sponsor
University of Campania Luigi Vanvitelli (class: other)

Record details

Record id
cardio:ct-nct03977116
Content hash
0880fd4c984e7f9e907352b49f587322ec2622af1b55765c2a81f475ac8e3846